Customizing rTMS treatment targeting for co-occurring alcohol use disorder and mild traumatic brain injury using multi-modal neuroimaging data as neurobiological markers
Guardado en:
Autores principales: | Amy Herrold, Sherri Livengood, Shan Siddiqi, Theresa Bender Pape |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f86eac1791564523b5fdfc565a8132d1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Preliminary evaluation of the clinical utility of miRNA as neurobiological markers of TBI diagnosis and rTMS treatment responsiveness
por: Theresa Bender Pape
Publicado: (2021) -
How to use multimodal neuroimaging to personalize rTMS parameters for depression treatment
por: Debby Klooster, et al.
Publicado: (2021) -
Superior antidepressant effect occurring 1 month after rTMS: add-on rTMS for subjects with medication-resistant depression
por: Chen SJ, et al.
Publicado: (2013) -
Combined rTMS/fMRI over the Motor and Prefrontal Brain Areas for Testing Therapeutic rTMS Protocols
por: Kai-Yen Chang, et al.
Publicado: (2021) -
Investigating EEG biomarker specificity to combined rTMS with psychotherapy: Psychotherapy, rTMS or sham? A blinded prediction study
por: Amourie Prentice, et al.
Publicado: (2021)